The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Role of NK cells in the control of metastatic spread and growth of tumor cells in mice
Abstract
The ability of BALB/c nude and C57BL/6 mice to eliminate tumor cells from the blood stream was severely impaired after a single inoculation of 0.2 ml of anti‐asialo BMI (asGMI) serum, diluted 1:40 to 1:320. The number of i.v.‐inoculated YAC‐I cells surviving in the lungs of BALB/c nude mice pretreated with anti‐asGMI serum was 28 times higher than in the control nude mice. In this respect, nude mice treated with anti‐asGMI behaved similarly to beige mice. The increase in the initial survival of tumor cells in the mice that was induced by pre‐treatment with anti‐asGMI resulted in a substantial increase in the number of artificial lung metastases that developed. In C57BL/6 +/+ mice treated with anti‐asGMI and in C57BL/6 beige mice, i.v. inoculation of B16 melanoma cells induced 10 times more metastatic foci in the lungs than in the control C57BL/6 +/+ mice. In contrast, in nude mice which possess higher levels of NK reactivity, metastatic growth was suppressed 7‐fold in comparison with intact C57BL/6 +/+ mice. In beige mice and in C57BL/6 +/+ mice treated with anti‐asGMI, multiple metastatic foci developed in the liver, whereas in control C57BL/6 +/+ and nude mice, no extrapulmonary metastases were found. These data indicate that B16 melanoma cells are able to grow in the liver, but their growth is ordinarily prevented by NK cells. The antimetastatic defense of C57BL/6 mice treated by anti‐asGMI could be restored by transplantation of 40 × 10 6 normal spleen cells. This antimetastatic effect of transplanted spleen cells was mediated by asGMI‐bearing cells, since after in vitro pre‐treatment of normal spleen cells with anti‐asGMI and complement, they lost their ability to inhibit the development of artifical metastases in the lungs of C57BL/6 mice. Suppression of NK reactivity by multiple injections of anti‐asGMI (every 4 to 5 days), in C57BL/6 mice inoculated intrafootpad (i.f.p.) with B16 melanoma or 3LL tumor cells, did not influence the growth of local tumors, but dramatically accelerated the development of spontaneous pulmonary metastases. These data demonstrate that NK cells may play an important role in resistance to the dissemination of tumor cells, and therefore contribute to the control of metastasis formation in mice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Natural Cell-Mediated Immunity
(1978) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60936-7 · Cited by 1,053
The Biology of Cancer Invasion and Metastasis
(1978) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60648-x · Cited by 801
Natural Cell-mediated Immunity Against Tumors
(1980) · Elsevier eBooks · doi:10.1016/b978-0-123-41350-5.x5001-4 · Cited by 665
Role of NK cells in tumour growth and metastasis in beige mice
Talmadge, J. E., Meyers, K. M., Prieur, D. J., & Starkey, J. R. (1980) · Nature · doi:10.1038/284622a0 · Cited by 527
Habu, S., Fukui, H., Shimamura, K., Kasai, M., Nagai, Y., Okumura, K., & Tamaoki, N. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.127.1.34 · Cited by 426
Self-citationDefinitive evidence that natural killer (NK) cells inhibit experimental tumor metastases in vivo.
Hanna, N., & Burton, R. C. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.127.5.1754 · Cited by 425
Role of Natural Killer Cells in the Destruction of Circulating Tumor Emboli23
Hanna, N., & Fidler, I. J. (1980) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/65.4.801 · Cited by 385
In vivo effect of anti-asialo GM1 antibody on natural killer activity
Kasai, M., Yoneda, T., Habu, S., Maruyama, Y., Okumura, K., & Tokunaga, T. (1981) · Nature · doi:10.1038/291334a0 · Cited by 271
Self-citationYoung, W. W., Hakomori, S., Durdik, J. M., & Henney, C. S. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.124.1.199 · Cited by 234
In vivo natural reactivity of mice against tumor cells
Riccardi, C., Santoni, A., Barlozzari, T., Puccetti, P., & Herberman, R. B. (1980) · International Journal of Cancer · doi:10.1002/ijc.2910250409 · Cited by 176
Self-citationGorelik, E., Fogel, M., Feldman, M., & Segal, S. (1979) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/63.6.1397 · Cited by 111
Self-citationKärre, K., Klein, G. O., Kiessling, R. W., Klein, G., & Roder, J. (1980) · International Journal of Cancer · doi:10.1002/ijc.2910260613 · Cited by 70
Gorelik, E., & Herberman, R. B. (1981) · International Journal of Cancer · doi:10.1002/ijc.2910270519 · Cited by 47
Self-citation
Cited by
Imai, K., Matsuyama, S., Miyake, S., Suga, K., & Nakachi, K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03231-1 · Cited by 1,190
NK cells and cancer: you can teach innate cells new tricks
Morvan, M. G., & Lanier, L. L. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2015.5 · Cited by 1,162
Ben-Eliyahu, Page, G. G., Yirmiya, R., & Shakhar, G. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990315)80:6<880::aid-ijc14>3.0.co;2-y · Cited by 429
Drug-Selected Human Lung Cancer Stem Cells: Cytokine Network, Tumorigenic and Metastatic Properties
Levina, V., Marrangoni, A. M., DeMarco, R., Gorelik, E., & Lokshin, A. E. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003077 · Cited by 407
Self-citationIntravascular Survival and Extravasation of Tumor Cells
Strilic, B., & Offermanns, S. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.07.001 · Cited by 397
Metadata
- Authors
- Gorelik, E., Wiltrout, R. H., Okumura, K., Habu, S., & Herberman, R. B.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 1982-07-15
- Volume
- 30
- Issue
- 1
- Pages
- 107-112
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2076617145
- Cited by
- 366
- References
- 13
- FWCI
- 7.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.